BACKGROUND: Choosing the most effective approach for treating rectal cancer with mesorectal fascia (MRF) involvement or closeness and synchronous distant metastases is a current clinical challenge. The aim of this retrospective study was to determine if upfront systemic chemotherapy and short-course radiotherapy (RT) with delayed surgery enables R0 resection. METHODS: Between March 2009 and October 2009, six patients were selected for upfront chemotherapy and short-course RT (5 × 5 Gy) with delayed surgery. The patients had locally advanced primary tumors with MRF involvement or closeness, as well as synchronous and potentially resectable distant metastases. Chemotherapy was administered to five patients between the end of the RT and surgery. All patients underwent total mesorectal excision (TME). RESULTS: The median patient age was 54 years (range 39-63). All primary and metastatic lesions were resected simultaneously. The median duration between short-course RT and surgery was 13 weeks (range, 7-18). R0 resection of rectal lesions was achieved in 5 patients. One patient, who had a very low-lying tumor, had an R1 resection. The median follow-up duration for all patients was 16.7 months (range, 15.5-23.5). One patient developed liver metastasis at 15.7 months. There have been no local recurrences or deaths. CONCLUSIONS: Upfront chemotherapy and short course RT with delayed surgery is a valuable alternative treatment approach for patients with MRF involvement or closeness of rectal cancer with distant metastases.
BACKGROUND: Choosing the most effective approach for treating rectal cancer with mesorectal fascia (MRF) involvement or closeness and synchronous distant metastases is a current clinical challenge. The aim of this retrospective study was to determine if upfront systemic chemotherapy and short-course radiotherapy (RT) with delayed surgery enables R0 resection. METHODS: Between March 2009 and October 2009, six patients were selected for upfront chemotherapy and short-course RT (5 × 5 Gy) with delayed surgery. The patients had locally advanced primary tumors with MRF involvement or closeness, as well as synchronous and potentially resectable distant metastases. Chemotherapy was administered to five patients between the end of the RT and surgery. All patients underwent total mesorectal excision (TME). RESULTS: The median patient age was 54 years (range 39-63). All primary and metastatic lesions were resected simultaneously. The median duration between short-course RT and surgery was 13 weeks (range, 7-18). R0 resection of rectal lesions was achieved in 5 patients. One patient, who had a very low-lying tumor, had an R1 resection. The median follow-up duration for all patients was 16.7 months (range, 15.5-23.5). One patient developed liver metastasis at 15.7 months. There have been no local recurrences or deaths. CONCLUSIONS: Upfront chemotherapy and short course RT with delayed surgery is a valuable alternative treatment approach for patients with MRF involvement or closeness of rectal cancer with distant metastases.
Authors: C A M Marijnen; I D Nagtegaal; E Kapiteijn; E Klein Kranenbarg; E M Noordijk; J H J M van Krieken; C J H van de Velde; J W H Leer Journal: Int J Radiat Oncol Biol Phys Date: 2003-04-01 Impact factor: 7.038
Authors: Rolf Sauer; Heinz Becker; Werner Hohenberger; Claus Rödel; Christian Wittekind; Rainer Fietkau; Peter Martus; Jörg Tschmelitsch; Eva Hager; Clemens F Hess; Johann-H Karstens; Torsten Liersch; Heinz Schmidberger; Rudolf Raab Journal: N Engl J Med Date: 2004-10-21 Impact factor: 91.245
Authors: Kevin F Birbeck; Christopher P Macklin; Nicholas J Tiffin; Wendy Parsons; Michael F Dixon; Nicholas P Mapstone; Cedric R Abbott; Nigel Scott; Paul J Finan; David Johnston; Philip Quirke Journal: Ann Surg Date: 2002-04 Impact factor: 12.969
Authors: Iris D Nagtegaal; Corrie A M Marijnen; Elma Klein Kranenbarg; Cornelis J H van de Velde; J Han J M van Krieken Journal: Am J Surg Pathol Date: 2002-03 Impact factor: 6.394
Authors: C A Marijnen; I D Nagtegaal; E Klein Kranenbarg; J Hermans; C J van de Velde; J W Leer; J H van Krieken Journal: J Clin Oncol Date: 2001-04-01 Impact factor: 44.544
Authors: Hong In Yoon; Woong Sub Koom; Tae Hyung Kim; Joong Bae Ahn; Minkyu Jung; Tae Il Kim; Hoguen Kim; Sang Joon Shin; Nam Kyu Kim Journal: PLoS One Date: 2016-08-18 Impact factor: 3.240
Authors: Michael Orth; Kirsten Lauber; Maximilian Niyazi; Anna A Friedl; Minglun Li; Cornelius Maihöfer; Lars Schüttrumpf; Anne Ernst; Olivier M Niemöller; Claus Belka Journal: Radiat Environ Biophys Date: 2013-10-20 Impact factor: 1.925
Authors: M Michael; S Chander; J McKendrick; J R MacKay; M Steel; R Hicks; A Heriot; T Leong; P Cooray; M Jefford; J Zalcberg; M Bressel; B McClure; S Y Ngan Journal: Br J Cancer Date: 2014-09-11 Impact factor: 7.640